Covidh Technologies EGM Voting Results Show Unanimous Approval for Corporate Changes
Covidh Technologies Limited's EGM voting results demonstrate unanimous shareholder support for major corporate restructuring, including the approved name change to iSERA Lifesciences Limited and appointment of four new directors. The detailed scrutinizer's report shows 100% approval across all five resolutions with strong participation from both promoter and public shareholders, reflecting confidence in the company's strategic direction and governance expansion.
*this image is generated using AI for illustrative purposes only.
Covidh Technologies Limited has released the detailed scrutinizer's report and voting results for its Extra-Ordinary General Meeting held on April 02, 2026, showing unanimous shareholder approval for all proposed resolutions including the company name change to iSERA Lifesciences Limited and new director appointments.
Meeting Overview and Regulatory Compliance
The EGM was conducted through video conferencing from 12:00 P.M. to 12:12 P.M. (IST) with Ms. Jayshree Suresh Jain, Managing Director, chairing the proceedings. A total of 25 public shareholders attended via video conferencing, while no promoter shareholders attended in person or via proxy. The meeting was held in compliance with Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
| Meeting Parameter: | Details |
|---|---|
| Total Shareholders on Record: | 1,052 |
| Shareholders Attended (VC): | 25 (Public) |
| Total Shares Outstanding: | 84,08,972 |
| Votes Received: | 15,34,755 |
| Voter Turnout: | 18.25% |
Mr. Anuj Gupta, Practising Company Secretary (Membership No. 31025), served as the scrutinizer and issued the consolidated report on April 03, 2026. Remote e-voting was available from March 30, 2026, at 9:00 A.M. (IST) through April 01, 2026, at 5:00 P.M. (IST), with services provided by MUFG Intime India Private Limited.
Voting Results and Unanimous Approval
All five resolutions received 100% approval from voting shareholders, with no votes cast against any resolution. The voting breakdown shows strong support across both promoter and public categories:
| Shareholder Category: | Shares Held | Votes Polled | Approval Rate |
|---|---|---|---|
| Promoter & Promoter Group: | 49,30,000 | 7,00,000 | 100% |
| Public - Non Institutions: | 34,78,972 | 8,34,755 | 100% |
| Public - Institutions: | 0 | 0 | N/A |
Major Corporate Changes Approved
The most significant resolution involved changing the company name from Covidh Technologies Limited to iSERA Lifesciences Limited, which was approved as a special resolution. This name change also necessitated consequential alterations to the company's Memorandum of Association and Articles of Association.
| Resolution Details: | Type | Votes For | Votes Against |
|---|---|---|---|
| Name Change to iSERA Lifesciences: | Special | 15,34,755 | 0 |
| Director Appointments: | Ordinary (4 resolutions) | 15,34,755 each | 0 each |
New Board Appointments
Shareholders approved the appointment of four new directors through ordinary resolutions, representing a significant expansion of the company's board structure:
| Director Name: | Position | DIN |
|---|---|---|
| Mr. Dhairyasheel Vasantrao Yadav: | Executive Director | 07551888 |
| Mr. Nandkumar Subhash Kadam: | Executive Director | 07551886 |
| Mr. Pratap Dadasaheb Deshmukh: | Non-Executive, Non-Independent Director | 07551567 |
| Ms. Ritu Dhanraj Garad: | Non-Executive, Non-Independent Director | 11503075 |
The appointments add two executive directors and two non-executive directors to strengthen corporate governance and operational oversight. All director appointment resolutions were categorized as having promoter group interest.
Regulatory Documentation and Compliance
The company submitted the voting results and scrutinizer's report to BSE Limited on April 03, 2026, in compliance with regulatory requirements. The documentation was digitally signed by Deepakshi, Company Secretary & Compliance Officer (Mem. No. A76335), and countersigned by the meeting chairperson.
The company maintains its registered office at Office No. A1-1202, 12th Floor, Boulevard Tower, Phase-2, CTS No. 11, Sadhu Vaswani Chowk, Camp, Pune – 411001, with corporate office located at Office No. 4, Kumar Prestige Point, 238 Shukrawar Peth, Pune City, Maharashtra – 411002. All proceedings were conducted in full compliance with Section 108 of the Companies Act, 2013, and Rule 20 of the Companies (Management and Administration) Rules, 2014.
Historical Stock Returns for Covidh Technologies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.99% | +8.22% | +51.24% | +587.19% | +2,783.42% | +8,865.63% |
What strategic business opportunities in the life sciences sector is iSERA targeting with this corporate rebranding from technology to healthcare?
How will the addition of four new directors impact the company's operational strategy and decision-making processes going forward?
What regulatory approvals or compliance requirements must iSERA Lifesciences complete to finalize the name change and business transformation?
19
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
